Thursday, October 24, 2019 10:54:46 AM
Such a CEO, and a refined gentleman to boot, leading a younger, motivated, BIEL team would constitute a Dream Team IMO. At the CEO levels, it's often who you know, recognition and earned credibility that opens doors widely and quickly.
My instincts lead me to think if Dr. Staelin were willing to help the potentially massive growth phase of BIEL at hand, it might be for a period of 24 to 36 months, maximum, plenty of time to get BIEL to many tens of millions in annual sales.
Feel strongly it's about informed professional demeanor and strong task assignment and completion, at the moment. Next phase could be more youthful, let's get the ship floating and moving forward first.
Given his approx. 8 1/2 years as BIEL Chair, during the regulatory ramp-up, and FDA leadership teamwork since 2017, just a thought, is Dr. Staelin a BIEL shareholder and if so, how substantial, anyone know? If he holds a large position, it would constitute a strong incentive, no?
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM